Recruiting

WELLNESS Program

Sponsor:

Saundra Jain

Code:

NCT07760896

Conditions

Wellness

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WILD 5 Wellness Program

Study Details

Brief summary:

The goal of this clinical trial is to learn whether a 30-day structured wellness program may support physical and emotional well-being in adults who are already taking a GLP-1 or dual GIP/GLP-1 medication for an FDA-approved indication. The study does not evaluate the GLP-1 medication itself or make changes to participants' medication treatment.

The main questions it aims to answer are:

1. Are there changes in participants' physical and emotional well-being after completing the 30-day wellness program?
2. Are there changes in areas such as mood, anxiety, functioning, mindfulness, self-compassion, eating-related behaviors, pain, and positive wellness?

Participants will:

1. Complete online questionnaires before and after the program.
2. Follow the WILD 5 Wellness program for 30 days, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition.
3. Complete a brief online tracking form each day during the 30-day program.

Conditions

Wellness

Study ID

NCT07760896

Start date

Sep 15, 2026

Status verified date

Sep, 2026

Completion date

Oct, 2027

Anticipated

Primary completion date

Oct, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria: Age 18 years or older. Able to speak, read, and understand English. Interested in supporting physical and emotional well-being. Access to a reliable Internet-enabled device, such as a computer, smartphone, or tablet.

Possess basic skills needed to complete online study forms. Currently prescribed and taking a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist by a licensed healthcare practitioner.

Report that the medication was prescribed for an FDA-approved indication, such as type 2 diabetes mellitus, chronic weight management for obesity or overweight with at least one weight-related condition, moderate-to-severe obstructive sleep apnea in adults with obesity, or another FDA-approved cardiometabolic indication.

Willing to complete online consent, registration, program measures, and daily tracking forms.

Willing to participate in the 30-day WILD 5 Wellness program delivered as part of the GLOW Study.

\-

Exclusion Criteria: Under 18 years of age. Unable to speak, read, or understand English. Do not have access to a reliable Internet-enabled device. Do not possess basic skills needed to complete online study forms. Not currently prescribed and taking a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist by a licensed healthcare practitioner.

Report that the medication was not prescribed for an FDA-approved indication. Pregnant or planning to become pregnant in the next 30 days. Currently have thoughts about harming themselves or someone else. Currently experiencing symptoms suggestive of active psychosis. Unwilling or unable to complete the required online study forms or participate in the 30-day

\-

Study Design

Enrollment

200 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: WILD 5 Wellness Program

Participants will complete the 30-day WILD 5 Wellness program, which includes daily practices related to exercise, mindfulness, sleep, social connection, and nutrition.

Interventions

WILD 5 Wellness Program

A 30-day structured wellness program that includes daily practices in five areas: exercise, mindfulness, sleep, social connection, and nutrition. Participants complete the wellness practices independently and complete daily online tracking during the 30-day program.

Primary outcome measure

  • Change in HERO Wellness Scale Total Score From Baseline to Post-Program [ Time Frame: Baseline and end of 30-day intervention ]

Central Contacts and Locations

Central contacts

Saundra Jain, MA, PsyD, LPC

888-252-7806saundrajain@gmail.com

Locations

The GLOW Study

Recruiting

The Colony, Texas, United States, 75056

Contacts

Saundra Jain, MA, PsyD, LPC

888-252-7806saundrajain@gmail.com

saundrajain@gmail.com

Principal Investigator:

Saundra Jain, MA, PsyD, LPC

More Information

Sponsor

Saundra Jain

Last update posted

Sep 3, 2026

Last verified

Sep, 2026

Keywords

  • GLP-1
  • GLP-1 Receptor Agonist
  • GIP/GLP-1 Receptor Agonist
  • Lifestyle Intervention
  • WILD 5 Wellness
  • Physical Well-Being
  • Emotional Well-Being
  • Self-Management

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Saundra Jain on 2026-09-03.